You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pro250 Arg Mutation

Showing 1 - 25 of 2,602
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muenke Syndrome (FGFR3-Related Craniosynostosis)

Completed
  • Craniosynostosis
  • Muenke Syndrome
    • Washington, District of Columbia
    • +1 more
    Mar 24, 2020

    Heart Failure Trial in Milan (L-arginine and liposomal vitamin C)

    Recruiting
    • Heart Failure
    • L-arginine and liposomal vitamin C
    • Milan, Lombardia, Italy
      Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
    Sep 12, 2023

    Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

    Active, not recruiting
    • Mycobacterium Infections, Nontuberculous
    • Birmingham, Alabama
    • +110 more
    Jan 23, 2023

    Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

    Completed
    • Asthma
    • Fluticasone with salmeterol
    • +3 more
    • Hackensack, New Jersey
    • +2 more
    Oct 12, 2022

    The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

    Recruiting
    • Beta-Thalassemia
    • ARMS PCR
    • Assiut, Egypt
      Faculty of Medicine Assiut University
    Jan 30, 2023

    Predictive Cancer Model Trial in Prague (colonoscopy)

    Recruiting
    • Predictive Cancer Model
    • colonoscopy
    • Prague, Czechia
      Military University Hospital
    Jun 25, 2023

    Malignant Tumor Trial in Wuhan (68Ga-HX01)

    Recruiting
    • Malignant Neoplasm
    • Wuhan, Hubei, China
      China, Hubei Province
    Aug 5, 2022

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

    Not yet recruiting
    • GATA2 Gene Mutation
    • Biological samples (blood and bone marrow samples).
    • Angers, France
    • +16 more
    Jul 31, 2023

    Advanced Solid Tumor Trial in Guangzhou (YL-17231)

    Recruiting
    • Advanced Solid Tumor
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 5, 2023

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

    Not yet recruiting
    • DDX41 Gene Mutation
    • For each person (index case or related) included in this study:
    • Bordeaux, France
    • +4 more
    Aug 28, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Type 3 Von Willebrand International Registries Inhibitor

      Active, not recruiting
      Has Results
      • Type 3 Von Willebrand's Disease
      • Von Willebrand Factor
      • Helsinki, Finland
      • +24 more
      Mar 21, 2022

      Myeloid Leukemia, MDS Trial (IFN-?)

      Not yet recruiting
      • Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Nov 15, 2023

      Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

      Active, not recruiting
      • Cystic Fibrosis
      • Birmingham, Alabama
      • +169 more
      Dec 22, 2022

      Breast Cancer Trial in New York (core needle biopsy, blood draw)

      Recruiting
      • Breast Cancer
      • core needle biopsy
      • blood draw
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Nov 9, 2023

      NSCLC Trial in Guangzhou (PLB1001)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Aug 15, 2023

      Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

      Recruiting
      • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
      • Montpellier, France
      • +7 more
      Dec 19, 2022

      Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NFS-02 Injection
      • (no location specified)
      Apr 6, 2023

      Trial

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NR082 Injection
      • Injection needle
      • (no location specified)
      Jan 30, 2023

      Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

      Recruiting
      • Advanced Solid Tumors
      • Grand Rapids, Michigan
      • +39 more
      Jan 25, 2023

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

        Completed
        • Cystic Fibrosis
        • Tucson, Arizona
        • +83 more
        Jan 20, 2023